Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 2.0× sales vs its 4.9× historical median P/S.
Fair value ≈ $83.46 · price $35.00 today
Undervalued · 58% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
@G_man1234 It pains me that this is not the same. A company by the name of Perceptive Life Sciences Master Fund, Ltd. Purchased 430k shares of $Drug on 10/15/2024. I will say that the companies making these sort of deals are all trading over $10/share right now though. Look at companies like $BRCTF & $ARWR which have both had deals similar in size to this in the last 6-7 months.
$IFRX $BRCTF Bioarctic still has not received their marketing authorization. https://www.bioarctic.com/en/chmp-issues-positive-recommendation-for-approval-of-lecanemab-in-the-eu/ let us see a deal like this with ROCHE and IFRX https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/
$BRCTF just want everyone to know this before so you can make a qualified decision
https://www.alzheimersresearchuk.org/news/newly-licensed-alzheimers-drug-lecanemab-not-available-on-nhs/
$ESALY $BRCTF finally- something good moving these stocks...
https://www.bioarctic.com/en/leqembi-lecanemab-authorized-for-early-alzheimers-disease-in-great-britain/
$DARE sold 20% of my shares. I said I am long (now time frame is 4 y since last year was 5). The reason for selling is that the continuous delayed milestones have reach the point in which are trully affecting company financing. The other reason is the disrespectul offering we have seen today. Still believe in the products abd the company. I am -35%, surprisingly my two highest risky players $AXSM and $BRCTF way compensate the losses I am taking from Dare. Hopefully things get better, if so, I may put the 20% back. From now I will be keeping an eye on the highly in debt but huge potential $BNGO
